Simpo, Florencia M.
HRN: 22-59-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/20/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/20/2023
03/26/2023
IVT
250mg
Q8
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes